Skip to main content

Advertisement

SpringerLink
Log in

Antiangiogenic Activity of Alofanib, an Allosteric Inhibitor of Fibroblast Growth Factor Receptor 2

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Alofanib is a potential allosteric inhibitor of FGFR2 used in oncology. The inhibitor blocks the extracellular part of the receptor and prevents its binding with the ligand. Alofanib suppressed proliferation of endothelial cells, their migration activity, and ability to form vessellike structures in vitro and significantly decreased the number of microvessels in Matrigel implant and in ovarian cancer (SKOV-3) xenograft in vivo. The results indicate that Alofanib can inhibit angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. Sh. Solomko, E. V. Stepanova, M. R. Lichinitser, and A. Yu. Baryshnikov, Ross. Bioterapevt. Zh., 6, No. 3, 3-7 (2007).

    Google Scholar 

  2. P. Carmeliet and R. K. Jain, Nature, 407, 249-257 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. T. Ho, C. L. Warneke, A. Hoang, et al., J. Clin. Oncol., 31, No. 6, Suppl., 386 (2013).

    Google Scholar 

  4. M. Korc and R. E. Friesel, Curr. Cancer Drug Targets, 9, No. 5, 639-651 (2009).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. B. Kwabi-Addo, M. Ozen, and M. Ittmann, Endocr. Relat. Cancer, 11, No. 4, 709-724 (2004).

    Article  CAS  PubMed  Google Scholar 

  6. V. Lindner, R. A. Majack, and M. A. Reidy, J. Clin. Invest., 85, No. 6, 2004-2008 (1990).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. K. A. O’Connell and M. Edidin, J. Immunol., 144, No. 2, 521-525 (1990).

    PubMed  Google Scholar 

  8. D. M. Ornitz, J. Xu, J. S. Colvin, et al., J. Biol. Chem., 271, No. 25, 15 292-15 297 (1996).

  9. A. Passaniti, R. M. Taylor, R. Pili, et al., Lab. Invest., 67, No. 4, 519-528 (1992).

    CAS  PubMed  Google Scholar 

  10. J. A. Takahashi, M. Fukumoto, K. Igarashi, et al., J. Neurosurg., 76, No. 5, 792-798 (1992).

    Article  CAS  PubMed  Google Scholar 

  11. I. Tsimafeyeu, F. Daeyaert, W. Yin, et al., Eur. J. Cancer, 50, Suppl. 6, 155 (2014).

    Article  Google Scholar 

  12. I. Tsimafeyeu, E. Stepanova, E. Solomko, et al., Cancer Res., 74, No. 19, Suppl., a1737 (2014).

    Article  Google Scholar 

  13. I. Tsimafeyeu, N. Wynn, M. Gordiyev, and A. Khasanova, Cancer Res., 73, No. 8, Suppl., a4069 (2013).

    Article  Google Scholar 

  14. I. Tsimafeyeu, N. Wynn, E. Zaveleva, and E. Stepanova, Eur. Urology Suppl., 12, No. 6, 126 (2013).

    Article  Google Scholar 

  15. I. Tsimafeyeu, E. Zaveleva, E. Stepanova, and W. Low, Invest. New Drugs, 31, No. 6, 1436-1443 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

    D. A. Khochenkov, E. Sch. Solomko, N. M. Peretolchina, O. O. Ryabaya & E. V. Stepanova

  2. N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia

    O. O. Ryabaya

Authors
  1. D. A. Khochenkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Sch. Solomko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. M. Peretolchina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. O. Ryabaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. V. Stepanova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. A. Khochenkov.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 160, No. 7, pp. 96-100, July, 2015

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khochenkov, D.A., Solomko, E.S., Peretolchina, N.M. et al. Antiangiogenic Activity of Alofanib, an Allosteric Inhibitor of Fibroblast Growth Factor Receptor 2. Bull Exp Biol Med 160, 84–87 (2015). https://doi.org/10.1007/s10517-015-3104-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-015-3104-5

Key Words

Search

Navigation